SMARCA4 and medulloblastoma: Loss-of-function SWI/SNF subunit mutations seem most prevalent in cancer, i.e., SCCOHT, NSCLC, point mutations have also been described, such as a small number of SMARCA4 missense mutations in medulloblastoma [115].